45 citations as recorded by crossref.

1. During the Early Stages of Staphylococcus aureus Biofilm Formation, Induced Neutrophil Extracellular Traps Are Degraded by Autologous Thermonuclease A. Sultan et al. 10.1128/IAI.00605-19
2. Management of chronic osteomyelitis of the femur and tibia: a scoping review Z. Arshad et al. 10.1302/2058-5241.6.200136
3. In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection M. Cunha et al. 10.1186/s12879-018-3069-x
4. General Assembly, Prevention, Local Antimicrobials: Proceedings of International Consensus on Orthopedic Infections J. Baeza et al. 10.1016/j.arth.2018.09.056
5. Clinical outcomes and complications of S53P4 bioactive glass in chronic osteomyelitis and septic non-unions: a retrospective single-center study S. Gatti et al. 10.1007/s10096-023-04737-z
6. Antimicrobial activity of bioactive glass S53P4 against representative microorganisms causing osteomyelitis – Real-time assessment by isothermal microcalorimetry M. Gonzalez Moreno et al. 10.1016/j.colsurfb.2020.110853
7. Neutrophil extracellular traps in the fight against biofilm-forming microorganisms: hunters or prey? I. Dolgushin & E. Mezentseva 10.36233/0372-9311-2020-97-5-9
8. Bioactive glass as dead space management following debridement of type 3 chronic osteomyelitis W. Oosthuysen et al. 10.1007/s00264-019-04442-7
9. Masquelet induced membrane technique for treatment of rat chronic osteomyelitis T. Cui et al. 10.3892/etm.2018.6573
10. 18F-NaF PET/CT imaging of bone formation induced by bioactive glass S53P4 after mastoid obliteration A. Timmermans et al. 10.1186/s41824-019-0065-3
11. Dead space management strategies in the treatment of chronic osteomyelitis: a retrospective review G. Epstein & N. Ferreira 10.1007/s00590-022-03392-y
12. A Bioglass-Based Antibiotic (Vancomycin) Releasing Bone Void Filling Putty to Treat Osteomyelitis and Aid Bone Healing R. Hasan et al. 10.3390/ijms22147736
13. Bioactive Glass Applications: A Literature Review of Human Clinical Trials M. Cannio et al. 10.3390/ma14185440
14. Bioactive glass, a new tool for the treatment in the diabetic foot recalcitrant osteomyelitis: A case series with 24-month follow-up Á. Rodríguez et al. 10.1016/j.foot.2021.101831
15. Bioactive glass in the treatment of chronic osteomyelitis in children: Description of four consecutive cases and literature review S. Lazzeri et al. 10.1016/j.injury.2022.07.014
16. Bioactive glass (S53P4) as obliteration material in subtotal petrosectomy: initial experience J. Lindeboom et al. 10.1017/S0022215122001116
17. Tissue-engineered bones with Adipose-Derived Stem Cells – Composite Polymer for Repair of Bone Defects E. Guo et al. 10.2217/rme-2022-0044
18. Prospective comparative analysis of efficacy of local debridement with or without vancomycin impregnated calcium sulphate in chronic osteomyelitis N. Jagadeesh et al. 10.1016/j.jor.2022.06.002
19. Bioactive glass in the treatment of chronic osteomyelitis—a valid option? F. Ziegenhain et al. 10.1097/OI9.0000000000000105
20. Safety and Efficacy of S53P4 Bioactive Glass in Osteomyelitis Management: A Systematic Review and Meta‐Analysis A. Nguyen et al. 10.1002/jbm.b.35597
21. Sol-gel silicate glass doped with silver for bone regeneration: Antibacterial activity, intermediate water, and cell death mode M. Mabrouk et al. 10.1016/j.bioadv.2022.212965
22. Calcium Sulfate Bone Substitutes in Clinical Use: History, Material Properties, Application, and Outlook for the Future J. Straub et al. 10.1002/jbm.b.35555
23. Synthesis and Characterization of Sol-Gel derived SiO2-Na2O-CaO-P2O5-SrO-Ag2O Bioglass T. Thet Swe et al. 10.1016/j.matpr.2022.06.496
24. Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions – a single center experience E. Steinhausen et al. 10.5194/jbji-6-73-2021
25. Tailored therapeutic release from polycaprolactone-silica hybrids for the treatment of osteomyelitis: antibiotic rifampicin and osteogenic silicates L. Gritsch et al. 10.1039/D1BM02015C
26. Non-Union Scoring System (NUSS): Is It Enough in Clinical Practice? D. Gaddi et al. 10.1007/s43465-022-00767-5
27. Behavioural response of cells and bacteria on single and multiple doped Sr and Ag S53P4 sol-gel bioglass T. Swe et al. 10.1016/j.ceramint.2020.04.094
28. The role of bioactive glass in the management of chronic osteomyelitis: a systematic review of literature and current evidence Y. Tanwar & N. Ferreira 10.1080/23744235.2019.1695059
29. Single versus two-stage management of long-bone chronic osteomyelitis in adults: a systematic review and meta-analysis A. Lari et al. 10.1186/s13018-024-04832-7
30. Enhancing Outcomes in Prosthetic Joint Infections: The Significance of the Periprosthetic Joint Infection Tumor, Node, and Metastasis (PJI-TNM) Classification and Biodegradable Antibiotic Beads M. Popa et al. 10.7759/cureus.66012
31. Bioactive glass S53P4 to fill-up large cavitary bone defect after acute and chronic osteomyelitis treated with antibiotic-loaded cement beads: A prospective case series with a minimum 2-year follow-up K. Kojima et al. 10.1016/j.injury.2021.05.030
32. Outcome Analysis of the Use of Cerament® in Patients with Chronic Osteomyelitis and Corticomedullary Defects M. Niemann et al. 10.3390/diagnostics12051207
33. Calcium sulfate in the management of osteomyelitis: A systematic review and meta-analysis of comparative studies G. Sheridan et al. 10.1097/MD.0000000000031364
34. Single-stage treatment of chronic localized tibial osteomyelitis with local debridement and antibiotic-loaded calcium sulfate implantation: a retrospective study of 42 patients C. Zhou et al. 10.1186/s13018-020-01721-7
35. Vancomycin-impregnated calcium sulfate beads compared with vancomycin powder in adult spinal deformity patients undergoing thoracolumbar fusion G. Xiong et al. 10.1016/j.xnsj.2020.100048
36. Role of Implantable Drug Delivery Devices with Dual Platform Capabilities in the Prevention and Treatment of Bacterial Osteomyelitis C. Billings & D. Anderson 10.3390/bioengineering9020065
37. Production of Staphylococcal Complement Inhibitor (SCIN) and Other Immune Modulators during the Early Stages of Staphylococcus aureus Biofilm Formation in a Mammalian Cell Culture Medium A. Sultan et al. 10.1128/IAI.00352-18
38. Reconstructive Options for Tibial Bone Defects P. McClure et al. 10.5435/JAAOS-D-21-00049
39. The Distraction Osteogenesis Callus: a Review of the Literature M. Rozis et al. 10.1007/s12018-021-09282-x
40. Tunable calcium phosphate cement formulations for predictable local release of doxycycline Q. Liu et al. 10.1016/j.mtla.2023.101769
41. Periodontal Therapy Using Bioactive Glasses: A Review J. Nicholson 10.3390/prosthesis4040052
42. Island Perforator Muscle Flaps for Chronic Osteomyelitis of the Lower Extremities: A Retrospective Analysis of 21 Consecutive Cases X. Zhao & Y. Shen 10.1097/PRS.0000000000009472
43. A better roadmap for designing novel bioactive glasses: effective approaches for the development of innovative revolutionary bioglasses for future biomedical applications E. Vafa et al. 10.1007/s11356-022-24176-1
44. Mid-term clinical results of chronic cavitary long bone osteomyelitis treatment using S53P4 bioactive glass: a multi-center study T. Van Vugt et al. 10.5194/jbji-6-413-2021
45. Antibiotic-loaded calcium sulfate in clinical treatment of chronic osteomyelitis: a systematic review and meta-analysis X. Shi et al. 10.1186/s13018-022-02980-2